Your browser doesn't support javascript.
loading
The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.
Kanozawa, Koichi; Noguchi, Yuichi; Sugahara, Souichi; Nakamura, Satoko; Yamamoto, Hirohisa; Kaneko, Keiko; Kono, Rika; Sato, Saeko; Ogawa, Tomonari; Hasegawa, Hajime; Katayama, Shigehiro.
Afiliação
  • Kanozawa K; Division of Nephrology and Hypertension, Blood Purification Center, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan. kanozawa@saitama-med.ac.jp.
  • Noguchi Y; Department of Endocrinology and Diabetes, Saitama Medical University, 38, Morohongo, Moroyama-machi Iruma-gun, Saitama, 350-0451, Japan.
  • Sugahara S; Shingashi Kidney Centre, 39-1, Shimoshingashi, Kawagoe-shi, Saitama, 350-1136, Japan.
  • Nakamura S; Sekishin Health Care Clinic, 25-18, Wakita Honcho, Kawagoe-shi, Saitama, 350-1123, Japan.
  • Yamamoto H; Kawagoe Ekimae Clinic, Ishikawa Kinenkai Medical Group, Kawagoe Ekimae Bld. 2F, 16-23, Wakita Honcho, Kawagoe-shi, Saitama, 350-1123, Japan.
  • Kaneko K; Higashi-Hannou Ekimae Clinic, Takahasi Bld.2, 3F, 3-5, Yanagicho, Hanno-shi, Saitama, 357-0035, Japan.
  • Kono R; Iruma Ekimae Clinic, Yokota Square Bld.4, 5F, 1-2-30, Toyooka, Iruma-shi, Saitama, 358-0003, Japan.
  • Sato S; Division of Nephrology and Hypertension, Blood Purification Center, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Ogawa T; Division of Nephrology and Hypertension, Blood Purification Center, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Hasegawa H; Division of Nephrology and Hypertension, Blood Purification Center, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Katayama S; Kawagoe Clinic, Saitama Medical University, 21-7 Wakita Honcho, Kawagoe-shi, Saitama, 350-1123, Japan.
Clin Exp Nephrol ; 22(4): 825-834, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29275488
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Fosfato de Sitagliptina / Nefropatias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Fosfato de Sitagliptina / Nefropatias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article